TGTXNasdaq United States
Market cap
$7.617 B
$49.76 +0.42%
Close of 7 Aug 2026
Revenue
$616.3M
#1802 by revenue
Earnings
$447.2M
#659 by earnings
Shares outstanding
153,069,053
Latest filing cover page
P/E ratio
17.0
Cap ÷ net income
Where these numbers come from
Share counts and financials for Tg Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.